Описание деятельности
Iveric Bio is a science-driven biopharmaceutical company focused on the discovery and development of novel treatments for retinal diseases with significant unmet medical needs. The Company is committed to having a positive impact on patients’ lives by delivering high-quality, safe and effective treatments designed to address debilitating retina diseases including all stages of age-related macular degeneration.
Правление & Наблюдательный совет
| Исполнительный директор |
| Glenn P. Sblendorio |
| Правление |
| David F. Carroll, Keith Westby, Pravin U. Dugel |
| Наблюдательный совет |
| Adrienne L. Graves, Axel Bolte, Calvin Roberts, Glenn P. Sblendorio, Jane Pritchett Henderson, Mark S. Blumenkranz |
Данные компании
| Имя: |
Iveric Bio Inc. |
| Адрес: |
Five Penn Plaza, Suite 2372,New York, NY 10001, USA |
| Телефон: |
+1-212-845-8200 |
| Факс: |
- |
| E-mail: |
info@ivericbio.com
|
| Интернет: |
https://ivericbio.com/ |
| Индустрия: |
Biotechnology |
| Сектор: |
Biotechnology |
| Подсектор: |
Biotechnology |
| Конец финансового года: |
31.12 |
| Акции в свободном обращении: |
- |
| Дата IPO: |
16.12.2016 |
